Food Or Edible As Carrier For Pharmaceutical Patents (Class 424/439)
  • Patent number: 11019836
    Abstract: Provided are food products having structures, textures, and other properties similar to those of animal meat, and that comprise substantial amounts of cell wall material. Also provided are methods and processes for producing such food products.
    Type: Grant
    Filed: August 1, 2016
    Date of Patent: June 1, 2021
    Inventors: Timothy Geistlinger, Michael S. Timmons
  • Patent number: 11013714
    Abstract: The present invention primarily relates to the use of Homoeriodictyol (HED) or a salt thereof or a mixture of HED and one or more salts thereof or a mixture of several salts thereof for reducing the gastric acid secretion-stimulating effect of N-Acetyl-4-aminophenol (Paracetamol).
    Type: Grant
    Filed: April 19, 2017
    Date of Patent: May 25, 2021
    Assignee: SYMRISE AG
    Inventors: Joachim Hans, Jakob Peter Ley, Susanne Paetz, Silke Middendorf, Kathrin Liszt, Veronika Somoza
  • Patent number: 11006658
    Abstract: Compositions comprising polysaccharides and oligosaccharides are provided. Methods for the formation of the compositions, including the enzymatic production of the oligosaccharides, and the uses of the compositions in foodstuffs, cosmetics, and nutraceuticals are also provided.
    Type: Grant
    Filed: April 9, 2020
    Date of Patent: May 18, 2021
    Assignee: Cambridge Glycoscience Ltd
    Inventor: Thomas J. Simmons
  • Patent number: 10993466
    Abstract: Methods of preparing a delivery system are described. Each method uses a first and second printing materials. The second printing material contains an active material such as a fragrance, flavor, malodor counteracting agent, and mixture thereof.
    Type: Grant
    Filed: April 25, 2016
    Date of Patent: May 4, 2021
    Inventors: Lewis Michael Popplewell, Franklin Pringgosusanto, Lulu Henson
  • Patent number: 10980786
    Abstract: The present invention generally relates to the early prevention of overweight, obesity, excessive fat accumulation and/or associated metabolic disorders in infants or children. For example, the present invention relates to the prevention of overweight, obesity, excessive fat accumulation and/or associated metabolic disorders in infants or children through appropriate nutrition for women desiring to get pregnant and/or during pregnancy and/or lactation. Embodiments of the present invention relate to the Vitamin B6 for use in the prevention of overweight, obesity, excessive fat accumulation and/or associated metabolic disorders in the offspring, wherein the vitamin B6 is administered to women desiring to get pregnant and/or to the mother during pregnancy and/or lactation and to maternal food compositions that can be used for this purpose.
    Type: Grant
    Filed: January 25, 2018
    Date of Patent: April 20, 2021
    Assignee: NESTEC S.A.
    Inventors: Cyrus Cooper, Peter David Gluckman, Keith Malcolm Godfrey, Catherine Mace, Irma Silva Zolezzi
  • Patent number: 10967043
    Abstract: This invention provides a method of colonic cleansing.
    Type: Grant
    Filed: June 10, 2019
    Date of Patent: April 6, 2021
    Assignee: Bausch Health Ireland Limited
    Inventors: Dennis Riff, Gary S. Jacob, Kunwar Shailubhai, Patrick H. Griffin
  • Patent number: 10967024
    Abstract: A synergistic herbal stimulant composition comprises a mixture, in powdered or extract form, of two or more herbal stimulant ingredients and at least one catalytic herbal ingredient, which effects a synergy between the herbal stimulant ingredients. The herbal stimulant ingredients are preferably selected from the group consisting of Horny Goat Weed (Epimedium Sagittatum), Rhodiola Root (Rhodiola Rosea), Elueuthero Root (Eleutherococcus), Nettle Leaf (Urticaria Dioica), Ashwagandha Root (Withania Somnifera), Maca Root (Lepidium Meyenii), Moringa Root (Moringa Oleifera), and Cowitch (Macuna Pruriens). The catalytic herbal ingredient is preferably Moses-in-a-basket (Tradescantia Spathacea).
    Type: Grant
    Filed: September 26, 2018
    Date of Patent: April 6, 2021
    Inventor: Aretha Duncan
  • Patent number: 10952461
    Abstract: The invention provides a smokeless tobacco product comprising a tobacco extract. In some embodiments, the smokeless tobacco product is translucent. The invention further provides methods for making and using the smokeless tobacco product. In certain embodiments, the smokeless tobacco product comprises isomalt, maltitol syrup, and a translucent tobacco extract prepared by ultrafiltration.
    Type: Grant
    Filed: January 31, 2018
    Date of Patent: March 23, 2021
    Assignee: R.J. Reynolds Tobacco Company
    Inventor: Darrell Holton, Jr.
  • Patent number: 10940129
    Abstract: The present disclosure relates to the use of lipophilic mercaptans for the treatment of pain sensitization. The lipophilic mercaptans disclosed can be used to decrease the formation of protein-aldehyde adducts within nociceptive nerves, thereby reducing sensitization to pain.
    Type: Grant
    Filed: August 21, 2018
    Date of Patent: March 9, 2021
    Inventor: David Michael Ott
  • Patent number: 10918125
    Abstract: Generating an optimised formulation for a foodstuff, comprises receiving at a processor physicochemical data pertaining to one or more plant extracts and operating the processor to calculate a time, Tmax, representing a time to reach a maximum concentration in plasma of at least one metabolite of the one or more plant extracts by applying the received physicochemical data to a mathematical model stored in memory. The processor is then operated to identify ones of the metabolites for which the calculated Tmax substantially corresponds with a target absorption time for the foodstuff; and to generate an optimised formulation for the foodstuff comprising the one or more plant extracts containing the identified metabolites. The physicochemical data include one or more of molecular mass (M), liphophilicity (log P) and Polar Surface Area (PSA).
    Type: Grant
    Filed: August 3, 2015
    Date of Patent: February 16, 2021
    Assignees: Commonwealth Scientific and Industrial Research Organisation, Horticulture Innovation Australia Limited
    Inventors: Rosalind B. Miller, Louise Elizabeth Bennett, Sophie Ngoc Bich Selby-Pham
  • Patent number: 10912295
    Abstract: The present invention relates to an agrochemical combination of (i) linolenic acid, a linolenic acid derivative, a linolenic acid breakdown component, or an ester thereof; and (ii) inositol, an inositol derivative or an inositol breakdown component. The invention also relates to agrochemical compositions comprising the same and the use such a combination for improving plant physiology.
    Type: Grant
    Filed: March 12, 2018
    Date of Patent: February 9, 2021
    Assignee: Crop Intellect Ltd.
    Inventor: Apostolos Papadopoulos
  • Patent number: 10900058
    Abstract: Methods are disclosed for the enzymatic preparation of galactooligosaccharide (GOS) from lactose using two different microbial lactase enzymes to maximize the extent of transgalactosylation during the digestion of lactose. Methods are also disclosed for avoiding the turbidity of a solution comprising GOS and lactose as it is adjusted for incubation with a yeast neutral lactase.
    Type: Grant
    Filed: June 6, 2019
    Date of Patent: January 26, 2021
    Inventor: Stephen Tomiuk
  • Patent number: 10857180
    Abstract: A pharmaceutical composition of the present invention is used for improving health, cure abnormalities and degenerative disease; achieve anti-aging effect of therapy and therapeutic effect on mammals. The pharmaceutical composition includes a pharmaceutical carrier and an isotope selective ingredient including at least one of a chemical element and a chemical compound containing the chemical element whereby isotope distribution in the at least one of the chemical element and the chemical compound containing the chemical element is different from natural distribution of at least one of isotopes wherein the part of selected isotope of the chemical element ranges from 0 to 100%. A method of the present invention uses the inventive pharmaceutical composition to improve health, cure abnormalities and degenerative disease and achieve therapeutic effect on mammals.
    Type: Grant
    Filed: December 29, 2018
    Date of Patent: December 8, 2020
    Assignee: Vector Vitale IP LLC
    Inventors: Peter Y Novak, Maxim V Temnikov, Oleksandr Balakin
  • Patent number: 10849948
    Abstract: This disclosure relates to a supplement, particularly a supplement for menopause.
    Type: Grant
    Filed: April 16, 2019
    Date of Patent: December 1, 2020
    Assignee: The Procter & Gamble Company
    Inventors: Jesus Velazquez, Leo Timothy Laughlin, II, Brian Kenneth Burgdorf
  • Patent number: 10842811
    Abstract: The present disclosure provides for methods and compositions for the treatment and prevention of antibiotic-resistant infections or pathogen colonization in critically ill patients in the intensive care unit (ICU) or in other populations at high risk for such infections.
    Type: Grant
    Filed: February 27, 2019
    Date of Patent: November 24, 2020
    Assignee: The Trustees of Columbia University in the City of New York
    Inventors: Julian Abrams, Daniel Freedberg
  • Patent number: 10835543
    Abstract: A method of increasing muscle mass and strength in mammals by orally administering a therapeutically effective amount of phosphatidic acid. The phosphatidic acid is preferably administered as a plurality of doses per day with at least one dose being administered during the anabolic window following exercise. Preferably, the method further includes the cotemporaneous administration of a therapeutically effective amount of creatine, optionally as phosphatidylcreatine. In addition or in the alternative, the method further includes the cotemporaneous administration of a therapeutically effective amount of leucine, optionally as phosphatidylleucine.
    Type: Grant
    Filed: May 31, 2013
    Date of Patent: November 17, 2020
    Assignee: Sports Nutrition Research, LTD.
    Inventors: Robert Clarke, Matthew Cahill, Brian Sweet
  • Patent number: 10835570
    Abstract: A dietary supplement including monacolin K, phytosterols, policosanols, resveratrol, trimethylglycine and coenzyme Q10 is provided.
    Type: Grant
    Filed: July 25, 2017
    Date of Patent: November 17, 2020
    Inventors: Guglielmo Buonamici, Marika Ballardin, Massimo Banti
  • Patent number: 10821185
    Abstract: Disclosed herein are triglyceride based formulations, compositions, and methods for the treatment of otic diseases and conditions. Such triglyceride based formulations and compositions are derived from medium chain triglycerides and allow for the delivery of a variety of therapeutic agents to the outer, middle, and/or inner ear.
    Type: Grant
    Filed: June 29, 2017
    Date of Patent: November 3, 2020
    Assignee: Otonomy Inc.
    Inventors: Robert Savel, Zhanpeng Zhang, Scott Coleman, Fabrice Piu, Hong Qi
  • Patent number: 10821489
    Abstract: An encapsulated reactant(s) having at least one encapsulant and at least one reactant. An outermost encapsulant is substantially non-reacting, impermeable and non-dissolving with water. The reactant(s) contribute to at least one reaction with contaminants in environmental media rendering the environmental media less harmful. Processes for using the encapsulated reactant in environmental media is also hereby claimed.
    Type: Grant
    Filed: March 6, 2017
    Date of Patent: November 3, 2020
    Assignee: Specialty Earth Sciences, LLC
    Inventors: Jason Swearingen, Lindsay Swearingen
  • Patent number: 10799471
    Abstract: Embodiments of the present invention are directed to methods, apparatus and articles of manufacture that feature omega-3 fatty acids co-processed with flavonoid and lipophilic antioxidants for improved stability.
    Type: Grant
    Filed: February 18, 2019
    Date of Patent: October 13, 2020
    Inventors: Bo Martinsen, Leif Andreas Riege
  • Patent number: 10780113
    Abstract: Pharmaceutical compositions for oral administration, in particular administration as an oral delivery system to be swallowed directly or capable of disintegration in the oral cavity, comprising iron oxy-hydroxide in high loading.
    Type: Grant
    Filed: December 23, 2016
    Date of Patent: September 22, 2020
    Assignee: Vifor Fresenius Medical Care Renal Pharma Ltd.
    Inventors: Ludwig Daniel Weibel, Erik Philipp
  • Patent number: 10765752
    Abstract: An iron-based composition is described. The composition can be used in conditions of total or relative iron deficiency. In particular, a solid composition is described, preferably in the form of powder or granules, for use in the treatment of disorders or diseases related to or derived from an iron deficiency. The composition is suitable for pediatric subjects, adolescents, athletes, men, women, pregnant women and elderly. Finally, a process for preparing the solid composition is also described.
    Type: Grant
    Filed: December 11, 2018
    Date of Patent: September 8, 2020
    Assignee: ALESCO S.R.L.
    Inventors: Andrea Lacorte, Germano Tarantino
  • Patent number: 10765718
    Abstract: A weight loss composition including banaba leaf extract, apple fruit extract, Rhodiola root extract, zinc chelate, and magnesium chelate are described. The weight loss composition may further include gardenia fruit extract, chromium chelate, Salacia extract, berberine, inositol, or mixtures thereof. Embodiments are also directed to a bulk food product and a weight management plan, which may be used in conjunction with the weight loss composition. Embodiments are also directed to kits and methods of use for treating or preventing obesity, promoting weight loss, and improving insulin resistance.
    Type: Grant
    Filed: February 2, 2018
    Date of Patent: September 8, 2020
    Assignee: GOLO LLC
    Inventors: Christopher Brian Lundin, Terry Shirvani
  • Patent number: 10765136
    Abstract: This document provides dietary supplement compositions as well as methods for using dietary supplement compositions to control glucose levels. For example, a dietary supplement composition including chromium (e.g., Chromium Oligofructose Complex), a sweet potato extract, and one or more of a mulberry extract, a green tea extract, a cinnamon extract, or a ginseng extract (e.g., Korean Red Ginseng extract) are provided.
    Type: Grant
    Filed: January 15, 2016
    Date of Patent: September 8, 2020
    Assignee: Melaleuca, Inc.
    Inventor: Jeremy Ivie
  • Patent number: 10729160
    Abstract: Method of reducing the mTOR pathway stimulating activity of amino acid containing nutritional materials. This method comprises treating an enzymatically hydrolysed protein material such as casein, whey, or soy protein with at least one enzyme capable of converting mTOR pathway stimulating amino acids and amino acid residues, such as leucine or methionine, into alternate chemical entities that do not stimulate or stimulate to a significantly lesser degree the mTOR pathway, while preserving the non-mTOR stimulating amino acids. These one or more alternate chemical entities should ideally be suitable for consumption, or alternatively be capable of being removed from the treated material through low cost extraction or conversion techniques. The material may then be sold as is, or alternatively packaged with low glycemic carbohydrates, healthy lipids, vitamins, and flavors and sold as a variety of different food products intended for an artificial diet intended to mimic the effects of caloric restriction.
    Type: Grant
    Filed: March 8, 2015
    Date of Patent: August 4, 2020
    Inventor: Ronald E Rosedale
  • Patent number: 10722586
    Abstract: Filmogenic compositions are described for topical anaesthetic bioadhesives (TABs) comprising a) a xanthan biopolymer matrix selected from Xanthomonas species and pathovars, including Xanthomonas campestris pathovars campestris and maninhotis, and Xanthomonas arboricola pathovar pruni, a producer of pruni xanthan, wherein the matrix is made of pure or combined xanthan varieties in any proportion, said matrix comprising between 1% and 95% by weight of the total weight of the composition, and additives or excipients; b) at least one anaesthetic, in a proportion of 0.1% to 50% by weight of the total weight of the composition. The topical anaesthetic bioadhesives (TABs) are also described, and they may be applied to the gingival mucosa and/or alveolar mucosa on the buccal (1) or lingual/buccal (2) surfaces with extensions and anatomical contours for crowns of the upper and lower dental arches.
    Type: Grant
    Filed: November 9, 2015
    Date of Patent: July 28, 2020
    Inventors: Claire Tondo Vendrusculo, Angelita Da Silveira Moreira, Adriana Fernandes Da Silva, Evandro Piva, Wellington Luiz De Oliveira Rosa, Francisco Augusto Burket Del Pino
  • Patent number: 10709158
    Abstract: The present disclosure discloses a nutritional composition for nourishing heart. The nutritional composition includes: 58-83 parts by weight of rice, 7-25 parts by weight of red beans, 5-16 parts by weight of lotus seeds, 2-7 parts by weight of lilium brownii, and 0.4-1.6 parts by weight of longan. The present disclosure, in view of the heart's characteristics that clearing away the heart fire and calming the nerves can ward off diseases and prolong life, and prevent premature aging, provides the prescription with the purpose of nourishing the blood and tranquillizing, is suitable to cooperate with staple foods for long-term consumption and easily accepted by people due to the good taste, and can achieve certain efficacies of nourishing the heart and tranquillizing.
    Type: Grant
    Filed: April 20, 2018
    Date of Patent: July 14, 2020
    Inventor: Zhonghua Ci
  • Patent number: 10711119
    Abstract: Carrageenan-based compositions containing a carrageenan, a starch, a plasticizer, water, and an optional buffer are disclosed, in which the carrageenan has both a potassium content of less than 4 wt. % and a viscosity configured to produce capsules on pressure-free rotary die equipment. Films and capsules can be formed from the carrageenan-based compositions.
    Type: Grant
    Filed: October 25, 2018
    Date of Patent: July 14, 2020
    Assignee: CP Kelco ApS
    Inventors: Thomas Worm, Jens Eskil Trudsø
  • Patent number: 10701964
    Abstract: The present application discloses a nutritional composition for tonifying spleen. The nutritional composition includes the following components of raw materials in parts by weight: rice 50-90, soybean 8-23, Semen coicis 2-12, Gorgon euryale seed 3-12, poria 0.4-1.6, and Chinese date 0.3-1.5. The present disclosure, in view of the spleen's special susceptibility to dampness pathogen, complies with the physiological function characteristics of the spleen itself, provides the prescription with an assistant effect of restoring the spleen's function as a starting point, is suitable to cooperate with staple foods for long-term consumption and easily accepted by people due to the good taste, and can achieve certain efficacies of tonifying the spleen and removing dampness.
    Type: Grant
    Filed: April 20, 2018
    Date of Patent: July 7, 2020
    Inventor: Zhonghua Ci
  • Patent number: 10702542
    Abstract: Preparations of glycan therapeutics, pharmaceutical compositions and medical foods thereof, optionally comprising micronutrients, polyphenols, prebiotics, probiotics, or other agents are provided and methods of making same. Also provided are methods of using said glycan therapeutics, e.g. for the modulation of human gastrointestinal microbiota and to treat dysbioses.
    Type: Grant
    Filed: April 26, 2019
    Date of Patent: July 7, 2020
    Inventors: Geoffrey A. von Maltzahn, Jared Silverman, Yvonne J. Yamanaka, John Miles Milwid, John M. Geremia
  • Patent number: 10702485
    Abstract: There is disclosed a composition for oral administration of O-desmethyltramadol. Compositions are also provided that are effective for overcoming resistance to tramadol in patients.
    Type: Grant
    Filed: July 8, 2012
    Date of Patent: July 7, 2020
    Assignee: Syntrix Biosystems Inc.
    Inventor: John A. Zebala
  • Patent number: 10701963
    Abstract: The present application discloses a nutritional composition for moisturizing lung. The nutritional composition includes the following components of raw materials in parts by weight: rice 55-90, wheat 7-25, Chinese yam 3-15, lily 2-9, polygonatum odoratum 0.2-1, and citron 0.1-1. The present disclosure, in view of the lung's characteristics of being not resistant to cold or heat, and susceptible to pathogen, complies with the lung's physiological function characteristics to regulate, and provides the prescription with nourishing yin and moisturizing lung, and resolving phlegm and relieving cough as a starting point, is suitable to cooperate with staple foods for long-term consumption and easily accepted by people due to the good taste, and can achieve certain efficacies of replenishing and restoring lung qi.
    Type: Grant
    Filed: April 20, 2018
    Date of Patent: July 7, 2020
    Inventor: Zhonghua Ci
  • Patent number: 10688111
    Abstract: The invention provides liquid formulations of compounds that act at sulfonylurea receptors that are suitable for intravenous and intra-arterial infusion. Compounds active at a sulfonylurea receptor include glibenclamide, tolbutamide, repaglinide, nateglinide, meglitinide, midaglizole, LY397364, LY389382, glyclazide, and glimepiride. Liquid formulations may be concentrated solutions suitable for storage; may be diluted (e.g., dilution of 1:1 or 1:1.2) suitable for bolus injections, and may be further diluted (e.g., dilution of 1:10 or 1:20 or more) for intravenous and intra-arterial infusion over an extended period of time. For example, a liquid formulation may include at least about 0.05 mg/ml glibenclamide in a water-based solution including 40% polyethylene glycol 300, 10% Ethanol, 50% water, at about pH 9. The solution may include a buffer, and is suitable for storage in refrigerator or at room temperature. This solution may be diluted 1:1, or more (e.g., 1:20) without precipitation of the glibenclamide.
    Type: Grant
    Filed: April 8, 2016
    Date of Patent: June 23, 2020
    Assignee: Biogen Chesapeake LLC
    Inventors: Sven Jacobson, Gillian Clarke, Rajinder Matharu
  • Patent number: 10682363
    Abstract: The present invention provides a composition comprising HMB and Vitamin D. Methods of administering HMB and Vitamin D to an animal are also described. Vitamin D and HMB are administered to increase muscle mass, strength, and functionality. The combination of Vitamin D and HMB together has a synergistic effect, which results in a surprising and unexpected level of improvement in muscle mass, strength and functionality.
    Type: Grant
    Filed: December 21, 2018
    Date of Patent: June 16, 2020
    Assignee: Metabolic Technologies, Inc.
    Inventors: John Rathmacher, John Fuller, Jr., Shawn Baier, Steve Nissen, Naji Abumrad
  • Patent number: 10660345
    Abstract: An object is to provide an acid milk beverage, which shows no precipitation or aggregation and reduced whey separation, and which has a refreshing texture, even in cases where the acid milk beverage has a low solids-not-fat concentration. An acid milk beverage characterized by containing an acid milk beverage base and a pectin having an intrinsic viscosity of 5.9 to 8.5, a degree of esterification of 74 to 80, and a calcium reactivity of 230 or less is provided.
    Type: Grant
    Filed: July 11, 2013
    Date of Patent: May 26, 2020
    Inventors: Masatoshi Nakano, Daichi Nihei, Yukiko Kobayashi, Claus Rolin, Soko Ushiyama, Hiroyuki Mamiya
  • Patent number: 10660353
    Abstract: Provided herein is a ready-to-eat (RTE) breakfast cereal with a unique texture. A RTE breakfast cereal provided herein can have a high slowly digestible starch content relative to commercially available RTE cereals. Also disclosed are methods of making a RTE breakfast cereal described herein.
    Type: Grant
    Filed: February 9, 2017
    Date of Patent: May 26, 2020
    Assignee: General Mills, Inc.
    Inventors: Tanhia D. Gonzalez, David C. Gonzalez, Christine Ng
  • Patent number: 10653733
    Abstract: The present invention provides nutritional compositions that are employed as oral supplementation to the human diet. The compositions of the present invention provide for supplementation to the diet of the cancer patient, as well as preventative dietary supplementation aimed at supporting the human immune system for those not currently suffering from cancer. The present invention is comprised of specific combinations of selected forms of unique sets of certain vitamins, minerals, protein, carbohydrates and phytochemicals.
    Type: Grant
    Filed: October 10, 2018
    Date of Patent: May 19, 2020
    Inventor: Houn Simon Hsia
  • Patent number: 10645951
    Abstract: The present invention relates to the field of the manufacture of food compounds derived from processing plant species, more specifically the process taught here provides products resulting from a process for obtaining compounds derived from vegetable raw material. The present invention describes the recovery of lecithin from the micelle/soy molasses, a residue obtained during the soy carrier concentrate (SPC) process. In a first aspect of the invention it describes a process for extracting phospholipids in conjunction with extraction of soluble sugars during the industrial process of obtaining (SPC). In a second aspect, the present invention describes an industrial process for recovering/removing such micelle phospholipids/soy molasses, cleaning and use for the production of soy lecithin.
    Type: Grant
    Filed: December 9, 2016
    Date of Patent: May 12, 2020
    Inventor: Paula Fernandes De Siqueira Machado
  • Patent number: 10609949
    Abstract: There is provided a tobacco product or a non-tobacco snuff product, including a magnesium carbonate, for conferring pH stability to the product and preventing growth of bacteria and fungi therein. The magnesium carbonate may contain hydroxide, oxide, and crystal water. The amount of magnesium carbonate ranges from 0.01 and 30% by weight of the dry bulk material. The product may be combined with additional pH regulators. The magnesium carbonate significantly increase the pH-stability in snus and non-tobacco snuff at the normal pH-range used in these products. The final product, which may be oral snuff or snus, or any tobacco-free snuff product, may be in particulate form, or shaped in a variety of forms. The product may be an oral product. The product may be packaged in a box, can or canister. Use of a magnesium carbonate for producing the products is also described.
    Type: Grant
    Filed: October 31, 2008
    Date of Patent: April 7, 2020
    Assignee: Swedish Match North Europe AB
    Inventors: Fredrik Hodin, Jorgen Lundin
  • Patent number: 10602763
    Abstract: The present invention is directed to a new process for supplementation of beverages with soluble and bio available iron in the form of ferric pyrophosphate. This process allows iron supplementation of beverages at low cost, without affecting either the original taste or the colour of the beverages. It is also directed to a concentrate ferric pyrophosphate-citrate solution and its use in the preparation of an iron enriched beverage. The invention also relates to a beverage obtainable by this process.
    Type: Grant
    Filed: March 9, 2012
    Date of Patent: March 31, 2020
    Assignee: DSM IP ASSETS BV
    Inventor: Georg Steiger
  • Patent number: 10596204
    Abstract: The use of propolis or an extract of propolis as a food supplement for preventing and/or combating pathological conditions associated with diet-induced obesity, and in particular type II diabetes, and a specific a composition suitable for this use.
    Type: Grant
    Filed: June 11, 2014
    Date of Patent: March 24, 2020
    Assignee: POLLENERGIE
    Inventor: Nicolas Cardinault
  • Patent number: 10582714
    Abstract: A method for enhancing cognitive development in a pediatric subject involving administering to the subject a nutritional composition which includes up to 7 g/100 Kcal of a fat or lipid; up to 5 g/100 Kcal of a protein or protein equivalent source; 0.25 g/100 Kcal to 16 g/100 Kcal of buttermilk; 5 mg/100 Kcal to 90 mg/100 Kcal of a source of long chain polyunsaturated fatty acid; and 0.015 g/100 Kcal to 1.5 g/100 Kcal of a prebiotic.
    Type: Grant
    Filed: October 14, 2015
    Date of Patent: March 10, 2020
    Inventors: Zihua Ao, Carol Lynn Berseth, Patricia Cobb, Juan M. Gonzalez, Elisha London, Minhthy Nguyen, James David Richards, Colin Rudolph, John D. Alvey, Yadilka Maldonado, Chenzhong Kuang, Yan Xiao, Dirk Hondmann
  • Patent number: 10576041
    Abstract: A dosage form with a first portion and a second portion. The first portion can be an immediate release portion and can comprise a pain reliever, which can be naproxen or naproxen sodium. The second portion can be an extended release portion and can comprise pseudoephedrine or a pharmaceutically acceptable salt thereof and/or dextromethorphan or a pharmaceutically acceptable salt thereof. The dosage form can optionally comprise a stabilizing agent. The dosage form can be adapted to maintain a therapeutically effective amount of pain reliever, pseudoephedrine, or a pharmaceutically acceptable salt thereof, and/or dextromethorphan, or a pharmaceutically acceptable salt thereof, for at least eight hours.
    Type: Grant
    Filed: September 25, 2017
    Date of Patent: March 3, 2020
    Assignee: The Procter & Gamble Company
    Inventors: Mark Edward Stella, John Richard Entwisle, Baltej Ludher, Jonathan E. Clark, Daren K. Aness, Guhan Balan, Andrew Nicholas Carr
  • Patent number: 10568337
    Abstract: A method of maintaining the liquidity of coconut oil (i.e. organic virgin) at room temperature (76° F.) and below, while reducing the coconut taste, and significantly increasing the fat burning/ketone producing property by combining coconut oil (i.e. organic virgin) with medium chain triglycerides (MCT) in predetermined specific ratios, that includes the step of heating the coconut oil to a prescribed temperature for approximately 24 hours (or until liquidity is achieved) and then mixing the liquefied coconut oil with a specified ratio of MCT oil. The resultant composition is a neutral tasting, fat burning/ketone producing oil that remains a liquid at room temperature 76° F. (and below) for use in cooking and foodstuffs such as a salad dressing. In an alternate embodiment, an additional amount of olive oil (i.e. organic extra-virgin) or an omega-3 based oil can be added to further reduce the coconut flavor and enhance the health benefits of the composition.
    Type: Grant
    Filed: January 30, 2019
    Date of Patent: February 25, 2020
    Inventors: Jayson Calton, Mira Calton
  • Patent number: 10563112
    Abstract: The present invention relates to a process for treating formation damage in an underground formation, including damage in the form of an oil-based drill-in fluid filter cake. The process makes use of a treatment fluid that contains a cyclodextrin or a starch and an enzyme capable of generating a cyclodextrin from the starch.
    Type: Grant
    Filed: March 2, 2015
    Date of Patent: February 18, 2020
    Assignee: Cleansorb Limited
    Inventor: Ralph Edmund Harris
  • Patent number: 10543237
    Abstract: This invention discloses new krill oil compositions characterized by having high amounts of phospholipids, astaxanthin esters and/or omega-3 contents. The krill oils are obtained from krill meal using supercritical fluid extraction in a two stage process. Stage 1 removes the neutral lipid by extracting with neat supercritical CO2 or CO2 plus approximately 5% of a co-solvent. Stage 2 extracts the actual krill oils by using supercritical CO2 in combination with approximately 20% ethanol. The krill oil materials obtained are compared with commercially available krill oil and found to be more bioeffective in a number of areas such as anti-inflammation, anti-oxidant effects, improving insulin resistances and improving blood lipid profile.
    Type: Grant
    Filed: June 29, 2018
    Date of Patent: January 28, 2020
    Inventors: Inge Bruheim, Snorre Tilseth, Daniele Mancinelli
  • Patent number: 10544473
    Abstract: A fungal strain Beauveria species bearing accession number MTCC 5184 is disclosed. The process for the preparation of an enzyme mix including at least one enzyme selected from, but not limited to protease, carbohydrase, and lipase from the disclosed Beauveria species and uses of the enzyme mix in various areas also disclosed.
    Type: Grant
    Filed: August 21, 2015
    Date of Patent: January 28, 2020
    Inventors: Seeta Laxman Ryali, Shiv Shankar, Snehal Vijay More, Harish Bansilal Khandelwal, Chandra Babu Kannan Narasimhan, Saravanan Palanivel, Padmanabhan Balaram
  • Patent number: 10527604
    Abstract: The present invention provides methods of assessing suitability of a pharmaceutical composition for medical use. The pharmaceutical composition comprises nanoparticles comprising paclitaxel coated with albumin and a non-nanoparticle portion comprising albumin and paclitaxel.
    Type: Grant
    Filed: March 5, 2016
    Date of Patent: January 7, 2020
    Inventors: Viktor Peykov, Willard Foss, Daniel W. Pierce, Neil P. Desai
  • Patent number: 10525483
    Abstract: A DAF skimmings separation system 10 that processes SPN/DAF skimmings 11 received from a meat processing facility to separate water and SPN-content solids includes a heating chamber coupled to a processor chamber having one or more pressurized discharge nozzles that expels DAF skimmings onto a spatter plate to cause SPN animal components within the DAF skimmings to break into smaller pieces denaturing the molecular structure and allowing the entrapped moisture to be evaporated within a heated airstream in the processing chamber, for separating nutritionally valuable SPN while reducing moisture content. A method of processing DAF skimmings to yield dryer SPN with reduced moisture content is disclosed.
    Type: Grant
    Filed: June 28, 2018
    Date of Patent: January 7, 2020
    Inventor: Riles Edward Hill
  • Patent number: 10525008
    Abstract: The invention relates to a microencapsulated amino acid composition and methods of manufacturing this composition. Amino acids, such as branched-chain amino acids, have low water solubility, poor hydrophilicity, and poor stability. Amino acids are thus difficult to be digested and absorbed. Consequently amino acids can hardly meet human needs of consuming. This microencapsulated amino acid composition that can quickly disperse and dissolve in cold water, resulting clear solution. The method includes (1) adding coating agents, wetting agents, or other excipients to the amino acid mixture, (2) modifying the surface of microencapsulated particles to considerably accelerate the wetting speed. In this composition, the weight ratio of amino acids and excipients is from 100/0.1 to 100/10.0.
    Type: Grant
    Filed: October 11, 2013
    Date of Patent: January 7, 2020
    Inventors: Wenzhong Wu, Jianbin Chen, Yuemei Zhang